
Overactive bladder (OAB) is a prevalent health issue that affects millions of people of all ages around the world. OAB comprises a constellation of symptoms that includes urinary frequency and urgency with or without urgency incontinence and can have a tremendous impact on an individual's quality of life. The American Urological Association OAB guidelines suggests starting with first- and second-line therapies that include conservative measures (avoidance of dietary bladder irritants and physical therapy) and pharmacotherapy (antimuscarinics or beta-3 agonists), respectively. When first- and second-line therapies are ineffective in providing relief of symptoms, one can consider more advanced therapies such as neuromodulation, onabotulinum toxin A injection of the bladder, and surgical reconstruction of the lower urinary tract. This chapter provides a case-based illustration of the approach to OAB.
Onabotulinum toxin A, Neuromodulation, Overactive bladder, Guidelines, Third-line therapies
Onabotulinum toxin A, Neuromodulation, Overactive bladder, Guidelines, Third-line therapies
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
